Data / Form D filings / BioRegenx Inc.
BioRegenx Inc.: Form D filings
BioRegenx Inc., a biotechnology company in Chattanooga, TN, filed 2 Form D notices with the SEC between 2021 and 2023. The latest, on April 4, 2023, reports $183,000 sold of a $3.6 million offering to 5 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 7407 ZIEGLER ROAD, Chattanooga, TN, 37421
- Phone
- (423) 580-7722
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Nevada
- Year incorporated
- 2021
- Revenue range
- $1,000,001 - $5,000,000
- Exemptions claimed
- Rule 506(c)
- SEC identifier (CIK)
- 1877104
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 4, 2023 | New notice | $3,600,000 | $183,000 | $3,417,000 | 5 | Jan 18, 2023 | sec.gov |
| Aug 6, 2021 | New notice | $3,000,000 | $615,456 | $2,384,544 | 23 | Jul 20, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Joseph S Bird | Promoter | |
| Robert S Doran | Promoter | |
| Sherri Adams | Director | |
| Suzanne Bird | Director | |
| Hans Vink | Executive Officer, Director, Promoter | |
| William Resides | Executive Officer, Director, Promoter | |
| Robert Long | Executive Officer, Director, Promoter | |
| Jody Walker | Director | |
| Gary Hennerberg | Executive Officer, Director | |
| Hitesh Juneja | Executive Officer |
Other biotechnology companies in Tennessee that filed recently
- Synomis, Inc. $30,000 · Oct 30, 2026
- TM Holding Companies, Inc. $3.7 million · Oct 8, 2026
Every Form D from the week of Apr 3, 2023 · All recent filings in Tennessee · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what BioRegenx Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.